Market revenue in 2023 | USD 2,271.5 million |
Market revenue in 2030 | USD 4,011.8 million |
Growth rate | 8.5% (CAGR from 2023 to 2030) |
Largest segment | Immunohistochemistry |
Fastest growing segment | Digital Pathology and Workflow |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Immunohistochemistry, In situ Hybridization, Primary & Special Staining, Digital Pathology and Workflow, Anatomic Pathology, Molecular Pathology |
Key market players worldwide | Roche Holding AG ADR, Abbott Laboratories, Thermo Fisher Scientific Inc, Siemens AG, Danaher Corp, BioMerieux SA, Qiagen NV, BD, Merck KGaA, GE Aerospace, Agilent Technologies Inc, Biogenex, Cell Signaling Technology, Bio SB, DiaGenic |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to tissue diagnostics market will help companies and investors design strategic landscapes.
Immunohistochemistry was the largest segment with a revenue share of 25.7% in 2023. Horizon Databook has segmented the Europe tissue diagnostics market based on immunohistochemistry, in situ hybridization, primary & special staining, digital pathology and workflow, anatomic pathology, molecular pathology covering the revenue growth of each sub-segment from 2018 to 2030.
European market is the second largest market in terms of revenue and is expected to witness significant growth in the forecast period. Companies in Europe are involved in extensive research on cancer and more specifically in development of advanced techniques for cancer detection.
Discovery of new cancer-related genes, studying tumor heterogeneity, and identification of alterations that contribute to tumorigenesis. The above factors are expected to increase the revenue generated from this region. Cancer is a public health burden across the European Union.
The European market is expected to grow owing to rise in aging population coupled with increase in access to healthcare. In August 2021, Unilabs, a Swiss company, in collaboration with Ibex Medical Analytics announced the launch of new AIpowered digital pathology platform across 16 European countries.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe tissue diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Europe tissue diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account